Paul Linneman
Clinical Nurse Specialist, Acute Care Columbia, MO Clinical Nurse Specialist
NPI 1801362710 CMS profile 10699098
1 Hospital Dr, Columbia, MO 65212
General payments
$1,614
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Paul Linneman of Columbia, MO is reported in the CMS Open Payments database as having received $1,614 across 23 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 83rd percentile of Clinical Nurse Specialist, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $683 | 11 | |
| 2024 | General | $76 | 2 | |
| 2023 | General | $570 | 6 | |
| 2022 | General | $249 | 2 | |
| 2021 | General | $36 | 2 |
Beside peers
- Paul Linneman
- Clinical Nurse Specialist, Acute Care median
- Middle half of Clinical Nurse Specialist, Acute Care
- National median
In program year 2025, general payments to Paul Linneman were reported at $683. Among 170 Clinical Nurse Specialist, Acute Care profiles paid that year, the median was $137 and the middle half received between $42 and $436.
Show as a table
| Year | Paul Linneman | Clinical Nurse Specialist, Acute Care median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $36 | $125 | $44–$370 | $132 |
| 2022 | $249 | $109 | $56–$356 | $149 |
| 2023 | $570 | $126 | $43–$435 | $160 |
| 2024 | $76 | $128 | $46–$385 | $164 |
| 2025 | $683 | $137 | $42–$436 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 20 billing codesPaid by Medicare
$7,867
Medicare patients
38
Services billed
198
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 74% | |
| Arthritis | 50% | |
| Heart failure | 34% | |
| Ischemic heart disease | 34% | |
| Chronic kidney disease | 34% | |
| Diabetes | 32% | |
| Atrial fibrillation | 32% | |
| COPD | 32% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
23 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Acute Care in Missouri
Christine Valdez
Clinical Nurse Specialist, Acute Care · Kansas City, MO
Katie Price
Clinical Nurse Specialist, Acute Care · Lebanon, MO
Laquita Lewis
Clinical Nurse Specialist, Acute Care · Saint Louis, MO
Emily Dodd
Clinical Nurse Specialist, Acute Care · Saint Louis, MO
Julie Lewis
Clinical Nurse Specialist, Acute Care · Columbia, MO
Related records
Clinical Nurse Specialist, Acute Care in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Acute Care
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.